Current PSA level-Between 4 to 10 - Page 5 of 7 Posts on Medivizor
Navigation Menu

Current PSA level-Between 4 to 10 Posts on Medivizor

Statin use is associated with freedom from rising levels of PSA after radiation therapy

Statin use is associated with freedom from rising levels of PSA after radiation therapy

Posted by on Dec 2, 2014 in Prostate cancer | 0 comments

In a nutshell The authors aimed to determine whether statin use can prevent prostate cancer recurrence after brachytherapy.  Some background Brachytherapy is a form of radiation, where a radiation source is internally placed at the tumor site. It is sometimes given in combination with external beam radiation therapy (EBRT – radiation...

Read More

What risk factors can influence surgery success in high-risk prostate cancer patients?

Posted by on Nov 27, 2014 in Prostate cancer | 0 comments

In a nutshell This study identified risk factors in high-risk prostate cancer patients that could influence the success of radical prostatectomy (RP). Some background Prostate cancer is a cancer of the prostate gland that makes up part of the male reproductive system. Though the majority of men will not die from this cancer, some forms can be...

Read More

How important is electronic tumor tracking?

How important is electronic tumor tracking?

Posted by on Nov 25, 2014 in Prostate cancer | 0 comments

In a nutshell This report discusses using a device to track tumor sites in follow-up biopsies in prostate cancer.  Some background Biopsies (the removal of tissue from the body and examination to establish the presence of cancer) are a very important part of active surveillance (patient monitoring instead of treatment) in early prostate...

Read More

Measuring PSA level between treatments can predict likelihood of recurrence

Measuring PSA level between treatments can predict likelihood of recurrence

Posted by on Nov 12, 2014 in Prostate cancer | 0 comments

In a nutshell This paper investigates measurement of the levels of the protein prostate-specific-antigen (PSA) as a predictor of cancer returning when the patient is treated with neoadjuvant androgen deprivation therapy and radiotherapy. Some background Prostate cancer patients have been shown to have higher rates of biochemical relapse-free...

Read More

Active surveillance for prostate cancer

Active surveillance for prostate cancer

Posted by on Oct 2, 2014 in Prostate cancer | 0 comments

In a nutshell This review provided an overview of active surveillance, including suitable patients, discontinuation rates and survival rates. Some background Radical prostatectomy (surgical removal of the prostate gland) in patients with low-risk prostate cancer has, in clinical trials, failed to improve overall and cancer-specific survival...

Read More

Can ERG protein expression be used to identify progression risk during active surveillance?

Can ERG protein expression be used to identify progression risk during active surveillance?

Posted by on May 18, 2014 in Prostate cancer | 0 comments

In a nutshell This article examined the association between ERG expression at prostate cancer diagnosis and the risk of disease progression during active surveillance. Some background One of the largest dilemmas in the treatment of prostate cancer is the management of a localized low-risk disease. Since radical prostatectomy (surgery to remove the...

Read More

Multi-parametric magnetic resonance imaging: Is active surveillance right for you?

Multi-parametric magnetic resonance imaging: Is active surveillance right for you?

Posted by on Jan 18, 2014 in Prostate cancer | 0 comments

In a nutshell This study evaluated the use of multi-parametric magnetic resonance imagining (MRI) in the selection of prostate cancer patients for active surveillance. Some background Active surveillance was introduced as a therapeutic strategy to avoid overtreatment of cancer patients with a relatively non-threatening disease. In active...

Read More

Treatment options for prostate cancer recurrence

Treatment options for prostate cancer recurrence

Posted by on Nov 28, 2013 in Prostate cancer | 0 comments

In a nutshell This review investigated treatment options following biochemical recurrence after primary treatment for prostate cancer. Some background Prostate cancer can be treated using a variety of methods, the most common being partial or full removal of the prostate gland, a procedure known as a prostatectomy. Other treatments include...

Read More

Is active surveillance safe?

Is active surveillance safe?

Posted by on Oct 10, 2013 in Prostate cancer | 0 comments

In a nutshell The study evaluated whether active surveillance (AS) is a safe approach and can prevent over-treatment in patients with prostate cancer.  Some background In the recent years, survival rates for prostate cancer patients have increased due to more advanced screening methods, which allow for early detection and prevention of...

Read More

The Gleason score can predict which prostate cancer patients can benefit the most from docetaxel therapy

Posted by on Aug 27, 2013 in Prostate cancer | 0 comments

In a nutshell This study re-examines data from a previous study and aims to identify which patients with prostate cancer would benefit the most from docetaxel (Taxotere) therapy. Some background Prostate cancer grows in response to testosterone, the main male sex hormone. In order to reduce the effect of testosterone, castration is the mainstay of...

Read More